HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

4th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 19-21 | Hybrid Event

September 19-21, 2024 | Rome, Italy
ECBB 2024

The SpACE-CCM: A facile and versatile cell culture medium-based biosensor for detection of SARS-CoV-2 spike-ACE2 interaction

Youngwook Ham, Speaker at Bioengineering Conferences
Korea Research Insitute of Bioscience and Biotechnology, Korea, Republic of
Title: The SpACE-CCM: A facile and versatile cell culture medium-based biosensor for detection of SARS-CoV-2 spike-ACE2 interaction

Abstract:

The COVID-19 pandemic is an ongoing global public health threat. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and binding of the SARS-CoV-2 spike to its receptor, angiotensin-converting enzyme 2 (ACE2), on host cells is critical for viral infection. Here, we developed a luminescent biosensor that readily detects interactions of the spike receptor-binding domain (RBD) and ACE2 in cell culture medium ('SpACE-CCM'), which was based on bimolecular complementation of the split nano luciferase-fused spike RBD and ectodomain of ACE2 and further engineered to be efficiently secreted from cells by adding a heterologous secretory signal peptide (SSP). Screening of various SSPs identified 'interferon-α+alanine-aspartate' as the SSP that induced the highest activity. The SpACE-CCM biosensor was validated by observing a marked reduction of the activity caused by interaction-defective mutations or in the presence of neutralizing antibodies, recombinant decoy proteins, or peptides. Importantly, the SpACE-CCM biosensor responded well in assay-validating conditions compared with conventional cell lysate-based NanoLuc Binary Technology, indicating its advantage. We further demonstrated the biosensor's versatility by quantitatively detecting neutralizing activity in blood samples from COVID-19 patients and vaccinated individuals, discovering a small molecule interfering with the spike RBD-ACE2 interaction through high-throughput screening, and assessing the cross-reactivity of neutralizing antibodies against SARS-CoV-2 variants. Because the SpACE-CCM is a facile and rapid one-step reaction biosensor that aptly recapitulates the native spike-ACE2 interaction, it would be advantageous in many experimental and clinical applications associated with this interaction.

Audience Take Away Notes:

  • If audiences want to know efficient secretion signal peptide, we will tell you how to use it
  • The audience will learn the highly efficient secretion signal peptide from my presentation
  • This research will help other researchers and companies to improve the secretion of secretory proteins in mammalian cells

Biography:

Youngwook Ham is currently a PhD student in the Department of Biomolecular Science at Korea National University of Bioscience and Technology. His research focuses on nucleic acid therapeutics and biosensor development. He has researched at the Nucleic Acid Therapeutics Research Center, Korea Research Institute of Bioscience and Biotechnology. In 2023, He published the SpACE-CCM biosensor in the Journal of Biosensor and Bioelectronics. He received the ‘Wunbong’ Young Scientist Award for this work at the 2023 International Conference KSBMB.

Watsapp